Axol Bioscience has acquired the ophthalmology business of Newcells Biotech, [...]

iXCells Biotechnologies and Rosebud Biosciences have announced a partnership to [...]

Soley Therapeutics has published a peer-reviewed study describing a method [...]

Nucleome Therapeutics has nominated its first preclinical development candidate, marking [...]

New research commissioned by Challenge Works and conducted by the [...]

Nucleome Therapeutics and Oxford University scientists have mapped the 3D [...]

Enhanced Genomics has secured an additional funding round, bringing its [...]

Causaly has introduced a new artificial intelligence system that it [...]

Biostate AI has launched K-Dense Beta, a multi-agent AI system [...]

James Anderson is the Chair of the INTREPID Alliance and the Executive Director of Global Health at the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), a leading global organization representing pharmaceutical companies. In his role at IFPMA, James spearheads efforts to address critical global health challenges, including antimicrobial resistance, pandemic preparedness, and non-communicable diseases.